Monopar Therapeutics Inc
NASDAQ:MNPR
Monopar Therapeutics Inc
NASDAQ:MNPR
Price:
107.7499
USD
-2.34%
Market Cap:
$721.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
China Conch Venture Holdings Ltd
HKEX:586
|
CN |
|
J
|
Julius Baer Gruppe AG
SIX:BAER
|
CH |
|
Seria Co Ltd
TSE:2782
|
JP |
|
Forward Air Corp
NASDAQ:FWRD
|
US |
|
Addtech AB
OTC:ADDHY
|
SE |
|
Lucid Group Inc
NASDAQ:LCID
|
US |
|
I
|
II-VI Inc
F:II6
|
US |
|
Repligen Corp
NASDAQ:RGEN
|
US |
|
Flame Acquisition Corp
NYSE:SOC
|
US |
|
Douyu International Holdings Ltd
NASDAQ:DOYU
|
CN |
|
V
|
Verizon Communications Inc
XETRA:BAC
|
US |
|
Edel SE & Co KgaA
XETRA:EDL
|
DE |
|
Yamana Gold Inc
TSX:YRI
|
CA |
|
T
|
TCS Group Holding PLC
XMUN:13T1
|
CY |
|
Adyen NV
F:1N8U
|
NL |
|
C
|
CLEANTEK Industries Inc
XTSX:CTEK
|
CA |
Multiples-Based Value
The Multiples-Based Value for Monopar Therapeutics Inc (MNPR) under the Base Case is hidden
USD.
Compared with the current market price of 107.7499 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MNPR Multiples-Based Value
LOCKED
